Page last updated: 2024-08-18

xanthenes and Cerebral Amyloid Angiopathy

xanthenes has been researched along with Cerebral Amyloid Angiopathy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Backhaus, R; Bauer, B; Bogdahn, U; Boy, S; Hartz, AM; Klünemann, HH; Mihaljevic, I; Schlachetzki, F; Schuierer, G; Soldner, EL; Wolf, A1

Other Studies

1 other study(ies) available for xanthenes and Cerebral Amyloid Angiopathy

ArticleYear
Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.
    Stroke, 2012, Volume: 43, Issue:2

    Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apolipoproteins E; Blood-Brain Barrier; Blotting, Western; Capillaries; Cell Membrane; Cerebral Amyloid Angiopathy; Cerebral Hemorrhage; Female; Fluorescent Dyes; Hemosiderosis; Humans; Magnetic Resonance Imaging; Male; Matrix Metalloproteinases; Mice; Mice, Transgenic; Middle Aged; Patient Selection; Phenotype; Stroke; Tight Junctions; Tomography, X-Ray Computed; Xanthenes

2012